12Biocompatibility, Resorption, and Foreign Body Response

FThe middle ear as a biological test bench

Whatever you place in the middle ear — a sculpted autograft incus, a ceramic head plate, a titanium strut — you are not simply parking an object in an empty box. You are introducing a foreign material into a moist, mucosa-lined, sometimes inflamed cavity that immediately begins to test it. Over hours to years the host adsorbs proteins onto the surface, sends in inflammatory cells, decides whether to tolerate, wall off, dissolve or expel what it finds, and gradually remodels the surrounding tissue around the implant. Two prostheses that look identical on the bench can have completely different fates in the ear, and the difference is almost entirely biological. This module is the story of that testing process and of the three verdicts the middle ear hands down: tolerance, resorption, and rejection by extrusion.

The history of ossiculoplasty is essentially a graveyard of materials that failed this test. Early enthusiasm for moldable polymers such as porous polyethylene (Plastipore) and the PTFE-carbon composite Proplast collapsed once their long-term behaviour was understood, and bioactive glass-ceramics that bonded beautifully to tissue were abandoned because they fragmented and dissolved [1988]. What survived — the patient’s own ossicle, dense hydroxyapatite, titanium — survived because the host tolerates it. Understanding why some materials are winners and others are abandoned is therefore not academic: it is the logic behind every choice you make at the prosthesis tray. The widget below distils that logic into a single report card you can interrogate material by material.

Notice the pattern as you click through the materials. The winners share a single property — the host leaves them alone — even though they differ wildly in stiffness, weight and handling. The abandoned materials each fail in their own way: one provokes inflammation, another dissolves. And the patient’s own ossicle, biologically perfect, carries its own quiet flaw: it can slowly resorb. Those failure modes — foreign-body reaction, resorption and extrusion — are the three sections that follow.

FBiocompatibility, bioinert and bioactive

Biocompatibilityis the property that lets a material coexist with living tissue without provoking chronic inflammation, toxicity or rejection. For an ossicular prosthesis the bar is demanding: the implant must be non-immunogenic and non-toxic to the middle-ear mucosa and the inner ear, it must neither dissolve in the cavity nor be absorbed systemically, and it must do all of this for the rest of the patient’s life. A material that satisfies these criteria becomes, in effect, invisible to the host; a material that does not becomes a nidus for chronic inflammation, mucosal proliferation and eventual failure.

It helps to split biocompatible materials into two families. A bioinert material is tolerated precisely because it does almost nothing: the host adsorbs a bland protein film, mounts a brief and self-limiting response, then covers the implant with a thin quiet layer of mucosa and leaves it be. Titanium is the archetype. In a rabbit middle-ear model, titanium pins were covered by regular mucosa with no inflammatory cellson the surface and no excess fibrous tissue, and they showed an affinity toward bone — the histological definition of being well tolerated [1998]. A bioactive material goes further and actively bonds to surrounding tissue or bone, a property called osseointegrationwhen the bond is to bone. Hydroxyapatite, a calcium-phosphate ceramic that mimics the mineral of bone, and the bioactive glass-ceramics both bond to tissue, which can stabilise an implant and reduce extrusion[1988].

Bioactivity is not an unmixed good, however, and this is a crucial nuance. The same surface reactivity that lets a glass-ceramic bond to tissue also lets it dissolve and fragment over time, and many of these ceramics are brittle and hard to contour, so a beautiful early bond gives way to late breakdown[1988]. Hydroxyapatite is more durable but still brittle — it fractures under force and is difficult to trim, which is why surgeons developed hybrid prostheses with a ceramic head and a more forgiving shaft [1992]. The lesson is that biocompatibility, durability and handling are separate axes, and the ideal material must score on all of them at once.

TThe foreign body response, stage by stage

When the host does not tolerate a material, it mounts a stereotyped foreign-body response, and its histological signature is one of the most useful things a trainee can recognise. The cascade begins within seconds: host proteins adsorb onto the implant surface to form a conditioning film that the cells actually encounter. Over the following days, neutrophils and then monocyte-derived macrophages arrive. If the macrophages can neither phagocytose nor digest the bulk material, they fuse into multinucleated foreign-body giant cells— the cellular hallmark of an unfriendly implant — and the tissue lays down a fibrous capsule around the object.

Porous polyethylene shows this textbook sequence in the ear. In retrieved Plastipore and Proplast prostheses and in animal models, the porous spaces are infiltrated by fibroblasts, round cells and large numbers of foreign-body giant cells, with progressive breakdown of the material itself [1983]. Examination of prostheses removed at revision surgery confirmed the fibrous ingrowth, the giant-cell reaction and the high migration and extrusion rates that ultimately damned these materials [1981]. Human temporal-bone histopathology pulls the whole picture together: alloplastic porous implants provoke a foreign-body reaction and fibrous encapsulation, whereas a well-tolerated implant sits quietly beneath a thin mucosal cover[2007]. The stepper below walks through the cascade and lets you switch between the tolerated and the failed pathway.

The clinical translation is direct. A material that drives this cascade keeps the middle ear chronically inflamed: mucosa proliferates, granulation tissue forms around the prosthesis head, and the implant is slowly walled off and pushed out. Recognising granulation around an old porous prosthesis, or foreign-body giant cells on a histology report, tells you that the material — not just bad luck — is the problem, and that revision with a bioinert implant is the answer.

TResorption: when biological grafts melt away

Biological grafts pose the opposite problem. They are exquisitely biocompatible — an autograft is the patient’s own tissue and provokes no rejection at all — but they are alive only in name. Once an ossicle is harvested, drilled and replaced, it is a devitalised piece of bone, and devitalised bone in a biologically active cavity can be slowly resorbed and remodelled by the host. Temporal-bone histopathology of human ears containing ossicular grafts shows exactly this: autograft and homograft ossicles frequently demonstrate devitalisation, areas of resorption and new-bone remodelling rather than persisting as the rigid struts they were placed to be [2007].

Resorption is the classic cause of delayed hearing deterioration after an initially successful autograft or homograft ossiculoplasty: the result is good for a year or two, then drifts as the graft thins and loses continuity with the stapes. Several factors push a graft toward this fate:

• A poorly aerated, chronically inflamed ear. The same hostile environment that breaks down a polymer accelerates the resorption of biological bone.
• Homograft over autograft.Homograft (donor) ossicles resorb more readily than the patient’s own, and sterilisation by irradiation reduces collagen and increases brittleness, hastening fragmentation — one of the reasons homografts have largely been abandoned.
• Ankylosis. Beyond thinning, a biological graft may fuse (ankylose) to the facial canal, bony annulus or promontory, fixing the chain and causing a late conductive loss that is awkward to revise.

This is the central trade-off of biological grafts. They win on tolerance and on the lowest extrusion rates of any material, but they lose on long-term dimensional stability. It is precisely why much of modern ossiculoplasty has moved toward dimensionally stable, non-resorbable alloplastics such as titanium and dense hydroxyapatite, while still reaching for the patient’s own incus when conditions favour it.

CExtrusion: when the host pushes the implant out

Extrusion is the most visible verdict of all: the prosthesis erodes through the eardrum and ends up sitting in the external canal, and the reconstruction fails. It is partly biological — a foreign-body reaction and chronic granulation loosen the implant — and partly mechanical, because a rigid head plate resting on the thin drum concentrates load on the epithelium and produces focal pressure necrosis. The two combine: an unfriendly material in an inflamed, retracting ear extrudes far more readily than a tolerated material in a healthy one. Reported extrusion rates track this story closely, from low single digits for autograft and capped bioinert prostheses up to the high figures that retired porous polyethylene.

Two findings dominate the clinical literature. First, material matters: a series of more than a thousand reconstructions found extrusion concentrated among the older porous prostheses and among ears that were poorly aerated, infected or undergoing revision, and showed that interposing cartilage between a rigid head and the drum markedly reduced it [2001]. Hybrid hydroxyapatite designs achieved a low extrusion rate of around 4%, a vast improvement on bare porous polymers [1992]. Second, and decisively, the ear matters more than the material. Statistical staging of ossiculoplasty outcomes shows that middle-ear factors — mucosal health, drainage and aeration — predict failure more strongly than the prosthesis you choose; the same bioinert implant that thrives in a dry, well-aerated ear will still extrude in a hostile one [2001].

CChoosing well: material, interface and environment

Put the three verdicts together and a practical hierarchy of defences emerges. First, choose a biocompatible material.For an alloplastic reconstruction that means a bioinert or durably bioactive implant — titanium or dense hydroxyapatite — and the deliberate avoidance of the abandoned porous polymers, whose foreign-body reaction and extrusion are well documented [1981, 1983]. Where the patient’s own incus is healthy and the ear is favourable, the autograft remains an excellent choice for its unmatched tolerance and minimal extrusion, accepting the small long-term risk of resorption[2007].

Second, protect the interface.Even the most biocompatible head is rigid, so a thin disc of cartilage interposed between the head plate and the drum defuses the pressure necrosis that drives extrusion and keeps the hardware off the epithelium — the single most reliable mechanical safeguard, and the reason it is near-universal at the drum interface [2001]. Third, optimise the environment.Because the ear outweighs the implant, the surgeon’s most powerful lever is often not the prosthesis at all but the biology around it: eradicating disease, restoring aeration, healthy mucosa and good Eustachian-tube function, and staging the reconstruction when the middle ear is too hostile to accept any implant[2001].

The unifying idea is worth holding onto. The middle ear tests every material you implant, and it scores three things: does it tolerate the surface, does it leave the bulk intact, and does it keep the implant in place. The materials that win — titanium, dense hydroxyapatite, the patient’s own ossicle in a good ear — win on all three. The materials that were abandoned each failed on one. And because the host’s verdict depends as much on the ear as on the implant, the surgeon who optimises the biological environment is the one who most reliably turns a good material into a lasting reconstruction [2001].